NO952205L - Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter - Google Patents
Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenterInfo
- Publication number
- NO952205L NO952205L NO952205A NO952205A NO952205L NO 952205 L NO952205 L NO 952205L NO 952205 A NO952205 A NO 952205A NO 952205 A NO952205 A NO 952205A NO 952205 L NO952205 L NO 952205L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- medicaments
- heterocyclic carbamates
- carbamates
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Denne oppfinnelse vedrører heterocykliske karbamater med formelen (I) (R2) (I) fremgangsmåter for deres fremstilling og medikamenter inne- holdende disse.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4333761A DE4333761A1 (de) | 1993-10-04 | 1993-10-04 | Heterocyclische Carbamate, Verfahren zu ihrer Herstellung und Arzneimittel |
| PCT/EP1994/003280 WO1995009842A1 (en) | 1993-10-04 | 1994-10-04 | Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO952205L true NO952205L (no) | 1995-06-02 |
| NO952205D0 NO952205D0 (no) | 1995-06-02 |
Family
ID=6499349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO952205A NO952205D0 (no) | 1993-10-04 | 1995-06-02 | Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5679677A (no) |
| EP (1) | EP0649839A1 (no) |
| JP (1) | JPH08504216A (no) |
| AU (1) | AU684314B2 (no) |
| CA (1) | CA2148361A1 (no) |
| DE (2) | DE4333761A1 (no) |
| FI (1) | FI952324L (no) |
| NO (1) | NO952205D0 (no) |
| WO (1) | WO1995009842A1 (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7407922B2 (en) * | 2005-10-13 | 2008-08-05 | S.C. Johnson & Son, Inc. | Deodorizing compositions |
| US7261742B2 (en) | 2005-10-13 | 2007-08-28 | S.C. Johnson & Son, Inc. | Method of deodorizing a textile |
| JP5193866B2 (ja) * | 2006-08-08 | 2013-05-08 | あすか製薬株式会社 | キナゾリン誘導体 |
| US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
| WO2008091555A2 (en) | 2007-01-22 | 2008-07-31 | Gtx, Inc. | Nuclear receptor binding agents |
| US9623021B2 (en) | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
| CN101686680B (zh) | 2007-03-09 | 2015-12-09 | 伊沃泰克美国股份有限公司 | 作为p2x7调节剂的双环杂芳基化合物及其用途 |
| WO2011163594A2 (en) * | 2010-06-24 | 2011-12-29 | Alkermes, Inc. | Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| US9868728B2 (en) | 2010-10-29 | 2018-01-16 | Emory University | Quinazoline derivatives, compositions, and uses related thereto |
| US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| US9751888B2 (en) | 2013-10-04 | 2017-09-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| PE20160685A1 (es) | 2013-10-04 | 2016-07-23 | Infinity Pharmaceuticals Inc | Compuestos heterociclicos y usos de los mismos |
| SG10201808053XA (en) | 2014-03-19 | 2018-10-30 | Infinity Pharmaceuticals Inc | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders |
| US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
| US10160761B2 (en) | 2015-09-14 | 2018-12-25 | Infinity Pharmaceuticals, Inc. | Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same |
| WO2017161116A1 (en) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors |
| US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE36226B1 (en) * | 1935-11-11 | 1976-09-15 | Shimamoto Takio | Phthalazone derivatives |
| FR1460552A (fr) * | 1965-04-22 | 1966-03-04 | Agripat Sa | Additifs à des nourritures pour animaux |
| NL6702189A (no) * | 1967-02-14 | 1968-08-15 | ||
| DE1807685A1 (de) * | 1968-11-08 | 1970-08-06 | Chinoin Gyogyszer Es Vegyeszet | Neue Chinazolon-Derivate und Verfahren zur Herstellung derselben |
| CH540266A (de) * | 1968-12-04 | 1973-08-15 | Chinoin Gyogyszer Es Vegyeszet | Verfahren zur Herstellung von Chinazolon-Derivaten |
| JPS5418270B2 (no) * | 1971-12-06 | 1979-07-06 | ||
| AR205004A1 (es) * | 1973-10-30 | 1976-03-31 | Ishikawa M | Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona |
| US4293553A (en) * | 1978-08-11 | 1981-10-06 | Masayuki Ishikawa | 1-Phthalazone derivatives, and use thereof |
| JPS5976069A (ja) * | 1982-10-25 | 1984-04-28 | Showa Denko Kk | フタラゾン誘導体 |
| GB2127805A (en) * | 1982-09-13 | 1984-04-18 | Showa Denko Kk | Phthalazones |
| US4769367A (en) * | 1984-04-24 | 1988-09-06 | Glaxo Group Limited | Heterocyclic amino compounds |
-
1993
- 1993-10-04 DE DE4333761A patent/DE4333761A1/de not_active Withdrawn
- 1993-10-04 DE DE4345266A patent/DE4345266C2/de not_active Expired - Fee Related
-
1994
- 1994-10-04 FI FI952324A patent/FI952324L/fi unknown
- 1994-10-04 JP JP7510611A patent/JPH08504216A/ja active Pending
- 1994-10-04 US US08/446,867 patent/US5679677A/en not_active Expired - Fee Related
- 1994-10-04 WO PCT/EP1994/003280 patent/WO1995009842A1/en not_active Ceased
- 1994-10-04 AU AU77845/94A patent/AU684314B2/en not_active Ceased
- 1994-10-04 CA CA002148361A patent/CA2148361A1/en not_active Abandoned
- 1994-10-04 EP EP94115598A patent/EP0649839A1/en not_active Withdrawn
-
1995
- 1995-06-02 NO NO952205A patent/NO952205D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5679677A (en) | 1997-10-21 |
| FI952324A0 (fi) | 1995-05-12 |
| EP0649839A1 (en) | 1995-04-26 |
| DE4345266A1 (de) | 1995-06-29 |
| CA2148361A1 (en) | 1995-04-13 |
| WO1995009842A1 (en) | 1995-04-13 |
| FI952324A7 (fi) | 1995-05-12 |
| AU684314B2 (en) | 1997-12-11 |
| AU7784594A (en) | 1995-05-01 |
| JPH08504216A (ja) | 1996-05-07 |
| FI952324L (fi) | 1995-05-12 |
| DE4345266C2 (de) | 1996-12-19 |
| NO952205D0 (no) | 1995-06-02 |
| DE4333761A1 (de) | 1995-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO305074B1 (no) | Aminosyrederivater, medikamenter inneholdende disse forbindelser og anvendelser derav | |
| EP0528858A4 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv | |
| DK104292A (da) | Heterocycliske forbindelser og fremgangsmaade til deres fremstilling | |
| NO932620L (no) | Amindiol-proteaseinhibitorer | |
| DK256890D0 (da) | Benzo-piperidin-, -piperidyliden- og piperazinforbindelser, kompositioner indeholdende forbindelserne og fremgangsmaader til forbindelsernes fremstilling og anvendelse | |
| FI890311A0 (fi) | Kemiska foereningar. | |
| DK0417698T3 (da) | Aminosyrederivater med reninhæmmende egenskaber, fremgangsmåde til deres fremstilling, midler med indhold deraf og deres anvendelse | |
| ATE38036T1 (de) | Benzothiophenderivate als bronchodilatoren. | |
| NO840048L (no) | Disubstituerte prolinderivater, fremgangsmaate til deres fremstilling og deres anvendelse | |
| NO933524D0 (no) | Krystallisk tiagabinhydrokloridmonohydrat samt fremstilling og anvendelse derav | |
| GR71207B (no) | ||
| DK270789D0 (da) | Hirudin-derivater, deres fremstilling og anvendelse | |
| ATE48001T1 (de) | Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate. | |
| MY105538A (en) | Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them. | |
| PL286043A1 (en) | Method for manufacturing new proteins | |
| GR3034615T3 (en) | Aminophenylalanine derivatives, process for their production, their use and agents containing them as anti-coagulants. | |
| DK0998471T3 (da) | Heterocykliske forbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse | |
| ES2022342B3 (es) | Hidrazinas n-(opcinalmente sustituidas)-n'-sustituidas-n, n'-disustituidas, insecticidas. | |
| IL112099A (en) | N-oxides of 4-arylpiperazines and 4-arylpiperidines and pharmaceutical compositions containing them | |
| HUT37797A (en) | Process for production of tetrahydro-tieno-piridinderivatives and medical preparatives containing of such compounds | |
| ATE69220T1 (de) | Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen. | |
| NO943765L (no) | Aryloksybenzen-herbicidmidler | |
| DE69606777D1 (de) | Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel | |
| DK1000067T3 (da) | Thiazolobenzoheterocycliske forbindelser, deres fremstilling og lægemidler indeholdende forbindelserne | |
| NO992316L (no) | Benzensulfonamidderivater og legemidler inneholdende disse |